Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allostatix was a healthcare data company based in Cincinnati, Ohio, that specialized in predicting disease and mortality through the measurement of allostatic load. Founded in 2005, the company utilized neural networks to analyze health data and identify physiological wear and tear caused by chronic stress. Allostatix claimed its technology could predict the onset of various diseases three to five years in advance with up to 90% accuracy. The company's platform integrated biomarkers from inflammatory, metabolic, and neuroendocrine systems to provide a comprehensive health risk assessment. Despite receiving funding from Ohio State University and private investors, the company is currently inactive. Its approach represented an early application of artificial intelligence to preventive medicine and population health management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allostatix.